These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

397 related items for PubMed ID: 2105994

  • 1. Effects of combinations of transforming growth factor-beta 1 and tumor necrosis factor on induction of differentiation of human myelogenous leukemic cell lines.
    Kamijo R, Takeda K, Nagumo M, Konno K.
    J Immunol; 1990 Feb 15; 144(4):1311-6. PubMed ID: 2105994
    [Abstract] [Full Text] [Related]

  • 2. Synergistic suppression of the clonogenicity of U937 leukemic cells by combinations of recombinant human interleukin 4 and granulocyte colony-stimulating factor.
    Maekawa T, Sonoda Y, Kuzuyama Y, Inazawa J, Kimura S, Nakamichi K, Abe T.
    Exp Hematol; 1992 Nov 15; 20(10):1201-7. PubMed ID: 1385197
    [Abstract] [Full Text] [Related]

  • 3. Synergistic interactions of interleukin 1, interferon-beta, and tumor necrosis factor in terminally differentiating a mouse myeloid leukemic cell line (M1). Evidence that interferon-beta is an autocrine differentiating factor.
    Onozaki K, Urawa H, Tamatani T, Iwamura Y, Hashimoto T, Baba T, Suzuki H, Yamada M, Yamamoto S, Oppenheim JJ.
    J Immunol; 1988 Jan 01; 140(1):112-9. PubMed ID: 3275716
    [Abstract] [Full Text] [Related]

  • 4. Effects of transforming growth factor beta, tumor necrosis factor alpha, interferon gamma and LIF-HILDA on the proliferation of acute myeloid leukemia cells.
    Kerangueven F, Sempere C, Tabilio A, Mannoni P.
    Eur Cytokine Netw; 1990 Jan 01; 1(2):99-107. PubMed ID: 2129395
    [Abstract] [Full Text] [Related]

  • 5. Transforming growth factor-beta 1 enhances the suppression of human hematopoiesis by tumor necrosis factor-alpha or recombinant interferon-alpha.
    Sing GK, Keller JR, Ellingsworth LR, Ruscetti FW.
    J Cell Biochem; 1989 Feb 01; 39(2):107-15. PubMed ID: 2715197
    [Abstract] [Full Text] [Related]

  • 6. Transforming growth factor-beta potentiates vitamin D3-induced terminal monocytic differentiation of human leukemic cell lines.
    Testa U, Masciulli R, Tritarelli E, Pustorino R, Mariani G, Martucci R, Barberi T, Camagna A, Valtieri M, Peschle C.
    J Immunol; 1993 Mar 15; 150(6):2418-30. PubMed ID: 8383719
    [Abstract] [Full Text] [Related]

  • 7. Enhancement by transforming growth factor-beta 1 (TGF-beta 1) of the proliferation of leukemic blast progenitors stimulated with IL-3.
    Suzuki T, Bessho M, Hirashima K, Tohda S, Nagata K, Morio T, Imai Y, Nara N.
    J Cell Physiol; 1991 Sep 15; 148(3):396-403. PubMed ID: 1717497
    [Abstract] [Full Text] [Related]

  • 8. The role of granulocyte-macrophage colony-stimulating factor in induction of monocytic differentiation of HL-60 cells: synergistic interaction with 1 alpha, 25-dihydroxyvitamin D3 and interferon-gamma in inducing interleukin-1 beta.
    Nakamaki T, Kawakami K, Sato S, Hino K, Tomoyasu S, Tsuruoka N, Honma Y, Hozumi M.
    Anticancer Res; 1992 Sep 15; 12(5):1331-7. PubMed ID: 1444189
    [Abstract] [Full Text] [Related]

  • 9. Synergistic and antagonistic effects of recombinant human interleukin (IL) 3, IL-1 alpha, granulocyte and macrophage colony-stimulating factors (G-CSF and M-CSF) on the growth of GM-CSF-dependent leukemic cell lines.
    Santoli D, Yang YC, Clark SC, Kreider BL, Caracciolo D, Rovera G.
    J Immunol; 1987 Nov 15; 139(10):3348-54. PubMed ID: 3500218
    [Abstract] [Full Text] [Related]

  • 10. Synergistic regulatory effects of interleukin 6 and interleukin 1 on the growth and differentiation of human and mouse myeloid leukemic cell lines.
    Onozaki K, Akiyama Y, Okano A, Hirano T, Kishimoto T, Hashimoto T, Yoshizawa K, Taniyama T.
    Cancer Res; 1989 Jul 01; 49(13):3602-7. PubMed ID: 2786454
    [Abstract] [Full Text] [Related]

  • 11. Synergism of prostaglandin E2 plus TNF in induction of differentiation of human monocytoid leukemic U-937 cells.
    Hosoi T, Takeda K, Konno K.
    Anticancer Res; 1989 Jul 01; 9(3):615-8. PubMed ID: 2548432
    [Abstract] [Full Text] [Related]

  • 12. The growth response of Lin-Thy-1+ hematopoietic progenitors to cytokines is determined by the balance between synergy of multiple stimulators and negative cooperation of multiple inhibitors.
    Jacobsen SE, Ruscetti FW, Ortiz M, Gooya JM, Keller JR.
    Exp Hematol; 1994 Sep 01; 22(10):985-9. PubMed ID: 7522186
    [Abstract] [Full Text] [Related]

  • 13. Relationship of acivicin-induced monocytoid differentiation of human myeloid leukemia cells to acivicin-induced modulation of growth factor, cytokine, and protooncogene mRNA expression.
    Weinberg JB, Mason SN.
    Cancer Res; 1991 Feb 15; 51(4):1202-9. PubMed ID: 1997162
    [Abstract] [Full Text] [Related]

  • 14. Synergistic effect of IL-4 and TNF-alpha in the induction of monocytic differentiation of a mouse myeloid leukaemic cell line (WEHI-3B JCS).
    Leung KN, Mak NK, Fung MC, Hapel AJ.
    Immunology; 1994 Jan 15; 81(1):65-72. PubMed ID: 8132222
    [Abstract] [Full Text] [Related]

  • 15. Differentiation-inducing effect of recombinant human tumor necrosis factor alpha and gamma-interferon in vitro on blast cells from patients with acute myeloid leukemia and myeloid blast crisis of chronic myeloid leukemia.
    Geissler K, Tricot G, Leemhuis T, Walker E, Broxmeyer HE.
    Cancer Res; 1989 Jun 01; 49(11):3057-62. PubMed ID: 2497971
    [Abstract] [Full Text] [Related]

  • 16. Effect of cytokines on the proliferation and differentiation of acute promyelocytic leukemia cells: possible relationship to the development of "retinoic acid syndrome".
    Nakamaki T, Hino K, Yokoyama A, Hisatake J, Tomoyasu S, Honma Y, Hozumi M, Tsuruoka N.
    Anticancer Res; 1994 Jun 01; 14(3A):817-23. PubMed ID: 7521152
    [Abstract] [Full Text] [Related]

  • 17. Effects of transforming growth factor-beta and activin A on vitamin D3-induced monocytic differentiation of myeloid leukemia cells.
    Okabe-Kado J, Honma Y, Hayashi M, Hozumi M.
    Anticancer Res; 1991 Jun 01; 11(1):181-6. PubMed ID: 2018352
    [Abstract] [Full Text] [Related]

  • 18. Synergy of interleukin 3 and tumor necrosis factor alpha in stimulating clonal growth of acute myelogenous leukemia blasts is the result of induction of secondary hematopoietic cytokines by tumor necrosis factor alpha.
    Brach MA, Gruss HJ, Asano Y, de Vos S, Ludwig WD, Mertelsmann R, Herrmann F.
    Cancer Res; 1992 Apr 15; 52(8):2197-201. PubMed ID: 1373106
    [Abstract] [Full Text] [Related]

  • 19. Differentiation-inducing and cytotoxic effects of tumor necrosis factor and interferon-gamma in myeloblastic ML-1 cells.
    Craig RW, Buchan HL.
    J Cell Physiol; 1989 Oct 15; 141(1):46-52. PubMed ID: 2506196
    [Abstract] [Full Text] [Related]

  • 20. Interleukin 1, interleukin 6, tumor necrosis factor, and transforming growth factor beta increase cell resistance to tumor necrosis factor cytotoxicity by growth arrest in the G1 phase of the cell cycle.
    Belizario JE, Dinarello CA.
    Cancer Res; 1991 May 01; 51(9):2379-85. PubMed ID: 2015601
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.